Henry Schein, Inc. (NASDAQ:HSIC) Receives Consensus Recommendation of “Hold” from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has earned an average rating of “Hold” from the eleven analysts that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $81.09.

HSIC has been the topic of a number of research reports. Barrington Research upped their target price on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 28th. Piper Sandler upped their target price on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, February 26th. Jefferies Financial Group upped their price objective on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. Finally, Leerink Partnrs reiterated a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th.

Henry Schein Stock Performance

Shares of HSIC stock opened at $67.78 on Monday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. Henry Schein has a one year low of $60.01 and a one year high of $82.63. The business’s 50 day simple moving average is $73.46 and its 200 day simple moving average is $72.32. The stock has a market capitalization of $8.71 billion, a PE ratio of 21.52, a PEG ratio of 1.68 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). The business had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The business’s revenue was down 10.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.21 earnings per share. As a group, research analysts forecast that Henry Schein will post 5.07 earnings per share for the current year.

Insider Transactions at Henry Schein

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

A number of large investors have recently made changes to their positions in the business. Aurora Investment Counsel lifted its stake in shares of Henry Schein by 0.7% in the 3rd quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after purchasing an additional 140 shares during the period. Arizona State Retirement System boosted its stake in Henry Schein by 0.4% during the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after buying an additional 149 shares during the last quarter. Keene & Associates Inc. raised its stake in Henry Schein by 4.0% during the first quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock valued at $340,000 after purchasing an additional 175 shares in the last quarter. Wahed Invest LLC grew its position in Henry Schein by 9.2% in the fourth quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock worth $168,000 after acquiring an additional 187 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its holdings in Henry Schein by 1.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 10,798 shares of the company’s stock valued at $802,000 after buying an additional 194 shares during the period. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.